Resignation of non-executive director; and (2) continued suspension of trading
Filed with HKEX · Stock code 2627 · · 1 page · English
Summary by 6ix AI
The company confirmed that there are no disagreements with the board regarding this resignation. Additionally, trading of the company's H Shares has been suspended since early April and will remain so until further notice. The company will provide updates to shareholders and potential investors as necessary.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/resignation-of-non-executive-directorandx3b-and-2-continued-suspension-of-trading
Ab&B Bio-Tech Co., Ltd. JS on 6ix
Earlier from Ab&B Bio-Tech Co., Ltd. JS
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Quarterly update on resumption progress and continued suspension of trading
- List of directors and their roles and functions
- (I) resignation of executive director and chief financial officer (ii) nomination of executive directors (iii) appointment of chief financial officer (iv) change of members of board committees (v) appointment of board secretary and joint company secretary (vi) waiver from strict compliance with rules 3.28 and 8.17 of the listing rules (vii) change of authorized representative and (viii) continued suspension of trading
- Voluntary announcement - IND approval by china CDE for mRNA mpox vaccine
Follow Ab&B Bio-Tech Co., Ltd. JS into a list and get an email when it puts out news.
Follow Ab&B Bio-Tech Co., Ltd. JS